Curious about Doximity (DOCS) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Zacks
Abrir en Zacks
Curious about Doximity (DOCS) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Wall Street analysts forecast that Doximity (DOCS) will report quarterly earnings of $0.34 per share in its upcoming release, pointing to a year-over-year decline of 24.4%. It is anticipated that revenues will amount to $170.66 million, exhibiting an increase of 1.3% compared to the year-ago quarter.

Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.

Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.

While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.

That said, let's delve into the average estimates of some Doximity metrics that Wall Street analysts commonly model and monitor.

The collective assessment of analysts points to an estimated 'Revenues- Other' of $9.68 million. The estimate suggests a change of +6.9% year over year.

Based on the collective assessment of analysts, 'Revenues- Subscription' should arrive at $161.16 million. The estimate points to a change of +1.1% from the year-ago quarter.

The combined assessment of analysts suggests that 'Number of customers with at least $500,000 of TTM revenue' will likely reach 129 . Compared to the present estimate, the company reported 121 in the same quarter last year.

View all Key Company Metrics for Doximity here>>>

Over the past month, shares of Doximity have returned +15% versus the Zacks S&P 500 composite's -2.3% change. Currently, DOCS carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Doximity, Inc. (DOCS): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research